Core Points - JD.com will hold its annual general meeting of shareholders on June 20, 2025, at 3:00 p.m. Hong Kong time in Beijing [1] - No proposals will be submitted for shareholder approval; the AGM will serve as an open forum for discussion between shareholders and management [2] - The company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024, with the U.S. SEC, which includes audited financial statements [3] - JD.com is a leading supply chain-based technology and service provider, focusing on enabling consumers to purchase products anytime and anywhere [4]

OAK BROOK, Ill., May 28, 2025 (GLOBE NEWSWIRE) -- Portillo’s Inc. (Nasdaq: PTLO) (“Portillo’s” or “The Company”), the fast-casual restaurant concept known for its menu of American classics with a Chicago twist, today announced that Portillo’s leadership will appear at the following investor conferences: On Tuesday, June 3, 2025, CFO Michelle Hook will present at William Blair’s 45th Annual Growth Stock Conference at 12:20 p.m. Eastern Time. A copy of the presentation used will be made available at investors ...

Acquires FPSO Nganhurra to leverage redeployment opportunities BW Offshore has signed an agreement to acquire the FPSO Nganhurra, securing a high-quality production unit in a market where comparable opportunities are becoming increasingly scarce. The transaction includes a limited upfront payment, with additional consideration contingent upon the successful redeployment of the unit before June 2027. With visible project opportunities emerging over the next few years, having this asset in place enhances our ...

SalMar ASA will hold its annual general meeting on Wednesday 18 June 2025 at 11:00 CEST. The meeting will be held virtually through the general meeting portal administrated by Euronext Securities Oslo. Please find the notice of the Annual General Meeting (AGM) enclosed. The company published its annual report on 9 April 2025. The report is available at the company homepage, www.salmar.no, including other relevant documents for the general meeting. For further information, please contact:Håkon Husby, Head of ...

Core Viewpoint - Kvika banki hf. has received a request from Íslandsbanki hf. to enter into merger discussions, indicating potential consolidation in the banking sector [1] Group 1 - The Chairman of the Board and the CEO of Kvika banki hf. are involved in the initial stages of considering the merger proposal [1] - The Board of Directors of Kvika banki hf. will review the merger request and decide on the next steps for the bank [1] - This notice is classified as inside information under EU regulation on market abuse, highlighting the regulatory implications of the merger discussions [1]

Core Viewpoint - Idorsia Ltd held its Annual General Meeting (AGM) where shareholders overwhelmingly supported all proposals from the Board of Directors, indicating strong confidence in the company's future direction and leadership [1][2]. Corporate Governance - The AGM was attended by 166 shareholders representing 97,748,740 shares, which is 43.28% of the total outstanding shares [1]. - Shareholders approved the re-election of all Board members for a term until the conclusion of the AGM 2026, including Jean-Paul Clozel as Chairman [4]. - The company granted discharge to all members of the Board of Directors and the Executive Committee for the financial year 2024 [3]. Financial Performance - Shareholders approved the Annual Report 2024, the Consolidated Financial Statements 2024, and the Statutory Financial Statements 2024 [2]. - The appropriation of available earnings was approved, with the net loss for the year 2024 to be carried forward [3]. Compensation and Audit - The aggregate maximum amount of compensation for the Board of Directors and the Executive Committee for the upcoming terms was approved [5]. - Deloitte AG was re-elected as the statutory auditors for the financial year 2025 [6]. Company Vision and Strategy - Idorsia aims to challenge accepted medical paradigms and is focused on discovering, developing, and commercializing transformative medicines [8]. - The company is positioned to become a leading biopharmaceutical entity in Europe, leveraging its strong scientific core and promising development pipeline [9].

Press Release Supporting Nickel Downstream Industry in Indonesia, Danantara Indonesia and INA Announce Strategic Partnership with Eramet Jakarta, 28 May 2025 – The Indonesia Investment Management Agency, Danantara Indonesia, and the Indonesia Investment Authority (INA) announced the signing of a Memorandum of Understanding (MoU) with French mining company Eramet to explore the establishment of a strategic investment platform in the nickel sector, spanning upstream to downstream operations. The signing was w ...

The Board of Directors of Havila Kystruten AS hereby gives notice of the AnnualGeneral Meeting. The meeting will take place on Thursday, June 12th, 2025 at10:00 CEST.The Annual General Meeting will be held as a digital meeting with electronicvoting via Lumi platform. It is also possible to cast votes or give proxyauthorizations in advance. Notice of the Annual General Meeting together withall relevant documents is available at www.havilavoyages.com/nb/ir(http://www.havilavoyages.com/nb/ir).Further informati ...

Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns 28 May 2025Announcement no. 7 Pharma Equity Group (PEG) today announces the launch of a transformative investment strategy aimed at accelerating growth, diversifying its portfolio across Pharma and Medical Devices, including MedTech, and enhancing long-term shareholder returns. Central to this strategic launch is the contemplated establishment of a dedicated Investment Committee (IC) to ensure rigorous evaluation and ...

Core Points - Nykredit Realkredit A/S has published a supplement dated 28 May 2025 to its joint €15,000,000,000 Euro Medium Term Note Programme established on 8 May 2025 [1] - The EMTN Programme allows Nykredit Realkredit A/S to issue Subordinated Notes (Tier 2), Senior Non-Preferred Notes, and Senior Unsecured Notes [1] - The supplement and the EMTN Programme documentation are available for download on Nykredit's official website [1] Contact Information - Inquiries can be directed to Morten Bækmand Nielsen, Head of ALM & Investor Relations, at +45 44 55 15 21 or Birna Arnbjarnardóttir, Attorney-at-Law, at +45 44 55 16 90 [2]